Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare overall survival (OS) in patients treated with pertuzumab in addition to Herceptin® (trastuzumab) plus fluoropyrimidine plus cisplatin (TFP) versus patients treated with placebo in addition to TFP
Critère d'inclusion
- HER2-positive advanced gastroesophageal junction/gastric cancer